Thimerosal and autism?

Pediatrics

Volumn 111, Issue 3, 2003, Pages 674-679

  Nelson, Karin B ^a   Bauman, Margaret L ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERCURY; THIOMERSAL; VACCINE;

AUTISM; CHELATION THERAPY; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG SAFETY; HUMAN; IMMUNIZATION; MERCURIALISM; MOTOR ACTIVITY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; NOTE; ONSET AGE; PRIORITY JOURNAL;

ADOLESCENT; AUTISTIC DISORDER; BRAIN; CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; MERCURY POISONING; PRESERVATIVES, PHARMACEUTICAL; THIMEROSAL; VACCINES; WORLD HEALTH;

EID: 0037341235     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.111.3.674     Document Type: Note

References (60)

1. Bernard S, Enayati A, Redwood L, Roger H, Binstock T. Autism: a novel form of mercury poisoning. Med Hypotheses. 2001;56:462-471
2. Bernard S, Enayati A, Roger H, Binstock T, Redwood L. The role of mercury in the pathogenesis of autism. Mol Psychiatry. 2001;7:S42-S43
3. Kidd PM. Autism, an extreme challenge to integrative medicine. Part 1: the knowledge base. Altern Med Rev. 2002;7:292-316
4. http://www.safeminds.org
5. Kark RAP, Poskanzer DC, Bullock JD, Boylen G. Mercury poisoning and its treatment with n-acetyl-D, L-penicillamine. N Engl J Med. 1971;285:10-16
6. Eto K. Minamata disease. Neuropathology. 2000;20:S14-S19
7. Cinca I, Dumitrescu I, Onaca P, Serbanescu A, Nestorescu B. Accidental ethyl mercury poisoning with nervous system, skeletal muscle, and myocardium injury. J Neurol Neurosurg Psychiatry. 1979;43:143-149
8. Amin-Zaki L, Majeed MA, Greenwood MR, Elhassani SB, Clarkson TW, Doherty RA. Methylmercury poisoning in the Iraqi suckling infant: a longitudinal study over five years. J Appl Toxicol. 1981;1:210-214
9. Korogi Y, Takahashi M, Hirai T, et al. Representation of the visual field in the striate cortex: comparison of MR findings with visual field deficits in organic mercury poisoning (Minamata disease). Am J Neuroradiol. 1997;18:1127-1130
10. Altmann L, Sveinsson K, Kramer U, et al. Visual functions in 6-year-old children in relation to lead and mercury levels. Neurotoxicol Teratol. 1998;20:9-17
11. Lebel J, Mergler D, Lucotte M, et al. Evidence of early nervous system dysfunction in Amazonian populations exposed to low-levels of methylmercury. Neurotoxicology. 1996;17:157-167
12. Wong V, Wong SN. Brainstem auditory evoked potential study in children with autistic disorder. J Autism Dev Disord. 1991;21:329-340
13. Gomot M, Giard MH, Adrien JL, Barthelemy C, Bruneau N. Hypersensitivity to acoustic change in children with autism: electrophysiological evidence of left frontal cortex dysfunctioning. Psychophysiology. 2002;39:577-584
14. O'Neill M, Jones RS. Sensory-perceptual abnormalities in autism: a case for more research? J Autism Dev Disord. 1997;27:283-293
15. Torres AD, Ashok AN, Hardiek ML. Mercury intoxication and arterial hypertension: report of two patients and review of the literature. Pediatrics. 2000;105(3):34. Available at www.pediatrics.org/cgi/content/full/105/3/e34
16. Boyd AS, Seger D, Vannucci S, Langley M, Abraham JL, King LE Jr. Mercury exposure and cutaneous disease. J Am Acad Dermatol. 2000;43:81-90
17. Fuortes LJ, Weisman DN, Graeff ML, Bale JF Jr, Tannous R, Peters C. Immune thrombocytopenia and elemental mercury poisoning. J Toxicol Clin Toxicol. 1995;33:449-455
18. Maghazaji HI. Psychiatric aspects of methylmercury poisoning. J Neurol Neurosurg Psychiatry. 1974;37:954-958
19. Ross WD, Sholiton MC. Specificity of psychiatric manifestations in relation to neurotoxic chemicals. Acta Psychiatr Scand. 1983;67(suppl 303):100-104
20. Powell TJ. Chronic neurobehavioural effects of mercury poisoning on a group of Zulu chemical workers. Brain Inj. 2000;14:797-814
21. Wheatley B, Barbeau A, Clarkson TW, Lapham LW. Methylmercury poisoning in Canadian Indians - the elusive diagnosis. Can J Neurol Sci. 1979;6:417-422
22. Ramirez G, Cruz MC, Pagulayan O, Ostrea E, Dalisay C. The Tagum study I: analysis and clinical correlates of mercury in maternal and cord blood, breast milk, meconium, and infants' hair. Pediatrics. 2000;106:774-781
23. Davidovitch M, Patterson B, Gartside P. Head circumference measurements in children with autism. J Child Neurol. 1996;111:389-393
24. Lainhart JE, Piven J, Szorek M, et al. Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry. 1997;36:282-290
25. Stevenson RE, Schroer RJ, Skinner C, Fender D, Simensen RJ. Autism and macrocephaly. Lancet. 1997;349:1744-1745
26. Courchesne E, Karns BS, Davis HR, et al. Unusual brain growth patterns in early life in patients with autistic disorder, an MRI study. Neurology. 2001;57:245-254
27. Aylward EH, Minshew NJ, Field K, Sparks BF, Singh N. Effects of age on brain volume and head circumference in autism. Neurology. 2002;59:175-183
28. Wing L, Potter D. The epidemiology of autistic spectrum disorders: is the prevalence rising? Ment Retard Dev Disabil Res Rev. 2002;8:151-161
29. Croen LA, Grether JK, Hoogstrate J, Selvin S. The changing prevalence of autism in California. J Autism Dev Disord. 2002;32:207-215
30. Aschner M, Walker SJ. The neuropathogenesis of mercury toxicity. Mol Psychiatry. 2002;7:S40-S41
31. Wecker L, Miller SB, Cochran SR, Dugger DL, Johnson WD. Trace element concentrations in hair from autistic children. J Ment Defic Res. 1985;29:15-22
32. Kerper LE, Ballatori N, Clarkson TW. Methylmercury transport across the blood-brain barrier by an amino acid carrier. Am J Physiol. 1992;262:R761-R765
33. Suzuki T, Miyama T, Toyama C. The chemical form and bodily distribution of mercury in marine fish. Bull Environ Contam Toxicol. 1973;10:347-355
34. Magos L. Review on the toxicity of ethylmercury, including its presence as a preservative in biological and pharmaceutical products. J Appl Toxicol. 2001;21:11-55
35. Magos L. The comparative toxicology of ethyl- and methylmercury. Arch Toxicol. 1985;57:260-267
36. Kakita A, Inenaga C, Sakamoto M, Takahashi H. Neuronal migration disturbance and consequent cytoarchitecture in the cerebral cortex following transplacental administration of methylmercury. Acta Neuropath. 2002;104:409-417
37. Sass JB, Haselow DT, Silbergeld EI. Methylmercury-induced decrement in neuronal migration may involve cytokine-dependent mechanisms: a novel method to assess neuronal movement in vitro. J Toxicol Sci. 2001;63:74-81
38. Nierenberg DW, Nordgren RE, Chang MB, et al. Delayed cerebellar disease and death after accidental after accidental exposure to dimethylmercury. N Engl J Med. 1998;338:1672-1676
39. Choi BH, Lapham LW, Amin-Zaki L, Saleem T. Abnormal neuronal migration, deranged cerebral cortical organization, and diffuse white matter astrocytosis of human fetal brain: a major effect of methylmercury poisoning in utero. J Neuropathol Exp Neurol. 1978;37:719-733
40. Kemper TL, Bauman ML. Neuropathology of infantile autism. Mol Psychiatry. 2002;7:S12-S13
41. Ritvo ER, Freeman BJ, Scheibel AB, et al. Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLASNAC Autopsy Research Report. Am J Psychiatry 1986;143:862-826
42. Bauman ML, Kemper TL. The Neurobiology of Autism. Baltimore, MD: The Johns Hopkins University Press; 1994
43. Bailey A, Luthert P, Dean A, et al. A clinicopathological study of autism. Brain. 1998;121:889-905
44. Black J. The puzzle of pink disease. J Roy Soc Med. 1999;92:478-481
45. Dally A. The rise and fall of pink disease. Soc Soc Hist Med Bull. 1997;10:291-304
46. Kondo K. Congenital Minamata disease: warnings from Japan's experience. J Child Neurol. 2000;15:458-464
47. Matsuishi T, Shiotsuki Y, Yoshimura K, Shoji H, Imuta F, Yamashita F. High prevalence of infantile autism in Kurume city, Japan. J Child Neurol. 1987;2:268-271
48. Tanoue Y, Oda S, Asano F, Kawashima K. Epidemiology of infantile autism in southern Ibaraki, Japan. J Autism Dev Disord. 1998;18:155-156
49. Sugiyama T, Abe T. The prevalence of autism in Nagoya, Japan: a total population study. J Autism Dev Disord. 1989;19:87-96
50. Kurita H. Clinical studies of pervasive developmental disorders in Japan. Psychiatry Clin Neurosci. 1996;50:165-170
51. Hoshino Y, Kumashiro H, Yashima Y, Tachibana R, Watanabe M. The epidemiological study of autism in Fukushima-ken. Folia Psychiatr Neurol Jpn. 1982;36:115-124
52. Institute of Medicine. Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Stratton K, Gable A, McCormick MC, eds. Washington DC: National Academy Press; 2001
53. Bingham M, Copes R, Srour L. Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders. Canadian Commmunicable Disease Report. 2002;28:69-80
54. Myers GL, Davidson PW, Cox C, Shamlaye C, Cernichiari E, Clarkson TW. Twenty-seven years studying the human neurotoxicity of methylmercury exposure. Environ Res. 2000;83:275-285
55. Aschner M. Mercury toxicity. J Pediatr. 2001;138:450-451
56. Grandjean P, Weihe P, White RF, et al. Cognitive deficit in 7-year old children with prenatal exposure to methylmercury. Neurotoxicol Teratol. 1997;19:417-428
57. Grandjean P, Budtz-Jorgensen E, White RF, et al. Methylmercury exposure biomarkers as indicators of neurotoxicity in children aged 7 years. Am J Epidemiol. 1999;150:301-305
58. Myers GJ, Davidson PW, Cox C, et al. Summary of the Seychelles child development study on the relationship of fetal methylmercury exposure to neurodevelopment. Neurotoxicology. 1995;16:711-716
59. Myers GH, Davidson PW, Palumbo D, et al. Secondary analysis from the Seychelles Child Development Study: the Child Behavior Checklist. Environ Res. 2000;84:12-19
60. Noterdaeme M, Minow F, Amorosa H. Applicability of the Child Behavior Checklist in developmentally delayed children. Z Kinder Jugendpsychiatr Psychother. 1999;27:183-188